Bryn Mawr Trust CO Bio N Tech Se Transaction History
Bryn Mawr Trust CO
- $5.44 Billion
- Q4 2024
A detailed history of Bryn Mawr Trust CO transactions in Bio N Tech Se stock. As of the latest transaction made, Bryn Mawr Trust CO holds 7 shares of BNTX stock, worth $761. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7
Previous 7
-0.0%
Holding current value
$761
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$894 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$479 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$467 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$206 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$197 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $26.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...